Biotechnology: Biological Products (No Diagnostic Substances)

Management ChangeAug 3, 2026, 04:46 PM

Eikon Therapeutics: Leon Chen, Joshua Wolfe Resign from Board

AI Summary

Eikon Therapeutics, Inc. announced that Leon Chen, Ph.D. and Joshua Wolfe resigned from its Board of Directors, effective July 31, 2026. The company stated that their resignations were not a result of any disagreement concerning the company's operations, policies, or practices.

Key Highlights

Leon Chen, Ph.D. resigned from the Board of Directors effective July 31, 2026
Joshua Wolfe resigned from the Board of Directors effective July 31, 2026
Resignations were not due to disagreements with the company's operations, policies, or practices

View SEC Filing

EIKN

Biotechnology: Biological Products (No Diagnostic Substances)

Eikon Therapeutics, Inc.

Price Impact